Last month, nearly 12,000 people gathered in Denver to talk about magic mushrooms (psilocybin), ecstasy (MDMA), ibogaine and ayahuasca, and to discuss the latest scientific research into these and other plant-based or synthetic ...
Jul 14, 2023
0
15
The brain is steadily engaged in thought. These internal communications are also usually bombarded with external sensory events. Hence, the impact of the two neuronal processes need to be permanently fine-tuned to avoid their ...
Apr 7, 2020
0
36
Psychedelic drugs such as LSD have a profound impact on human consciousness, particularly perception. Researchers at Yale and the University of Zurich provide new insight into the psychedelic effects of LSD on the brain and ...
Oct 26, 2018
6
1368
According to the World Health Organization more than three hundred million people worldwide are affected by major depressive disorder. Unfortunately, the antidepressants commonly used to treat them only work for 50% of the ...
Jan 17, 2018
0
2
A better understanding of how a key chemical messenger acts in the brain could lead to a radical shift in psychiatric care, according to a new paper.
Sep 5, 2017
2
1924
Many schizophrenic and depressed patients experience weight gain and type 2 diabetes in their quests for the life-changing benefits of a major class of antipsychotic drugs.
Aug 15, 2017
0
5
Individual symptoms, such as anxiety, avoidance and a heightened response to stress, can be transmitted from mother to child and even grandchildren by multiple nongenetic mechanisms, a new study by investigators at Weill ...
May 16, 2016
2
1019
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have uncovered a significant—and potentially treatable—relationship between a chemical that helps transmit signals in the brain and genetic mutations ...
Sep 30, 2015
0
43
Involuntary dyskinetic movements induced by treatment with levodopa (L-dopa) are a common problem for people with Parkinson's disease. Now, however, researchers at Karolinska Institutet and Lund University in Sweden seem ...
Feb 10, 2015
0
13
Research led by Charles Nichols, PhD, Associate Professor of Pharmacology and Experimental Therapeutics at the LSU Health New Orleans School of Medicine, has found that a psychedelic drug, (R)-DOI, prevents the development ...
Feb 9, 2015
0
22
